Literature DB >> 12144568

Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment.

J P Gisbert1, J M Pajares.   

Abstract

The prevalence of Helicobacter pylori infection in peptic ulcer disease complicated by gastric outlet obstruction seems to be, overall, lower than that reported in non-complicated ulcer disease, with a mean value of 69%. However, H. pylori infection rates in various studies range from 33% to 91%, suggesting that differences in variables, such as the number and type of diagnostic methods used or the frequency of non-steroidal anti-inflammatory drug intake, may be responsible for the low prevalence reported in some studies. The resolution of gastric outlet obstruction after the eradication of H. pylori has been demonstrated by several studies. It seems that the beneficial effect of H. pylori eradication on gastric outlet obstruction is observed early, just a few weeks after the administration of antimicrobial treatment. Furthermore, this favourable effect seems to remain during long-term follow-up. Nevertheless, gastric outlet obstruction does not always resolve after H. pylori eradication treatment and an explanation for the failures is not completely clear, non-steroidal anti-inflammatory drug intake perhaps playing a major role in these cases. Treatment should start pharmacologically with the eradication of H. pylori even when stenosis is considered to be fibrotic, or when there is some gastric stasis. In summary, H. pylori eradication therapy should be considered as the first step in the treatment of duodenal or pyloric H. pylori-positive stenosis, whereas dilation or surgery should be reserved for patients who do not respond to such medical therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144568     DOI: 10.1046/j.1365-2036.2002.01275.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  1990-2001 US general surgery chief resident gastric surgery operative experience: analysis of paradigm shift.

Authors:  N Joseph Espat; Evan S Ong; W Scott Helton; Lloyd M Nyhus
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

2.  A patient with impaired gastric motility.

Authors:  P A Paine; W Rees; C Babbs; J L Shaffer; G Armstrong; H Burnett; Q Aziz
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

3.  Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.

Authors:  Guilherme-Eduardo-Goncalves Felga; Fernando-Marcuz Silva; Ricardo-Correa Barbuti; Tomas Navarro-Rodriguez; Schlioma Zaterka; Jaime-Natan Eisig
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

4.  Two Cases of Helicobacter pylori-Negative Gastric Outlet Obstruction in Children.

Authors:  Raza A Patel; Susan S Baker; Wael N Sayej; Robert D Baker
Journal:  Case Rep Gastrointest Med       Date:  2011-08-25

Review 5.  Management of gastric outlet obstruction: Focusing on endoscopic approach.

Authors:  Su Jin Jeong; Jin Lee
Journal:  World J Gastrointest Pharmacol Ther       Date:  2020-06-09

6.  Is Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence.

Authors:  Vikram Kate; N Ananthakrishnan; Frank I Tovey
Journal:  Gastroenterol Res Pract       Date:  2013-03-27       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.